In the BioHarmony Drug Report Database

"Preview" Icon

Edotreotide

Ga-68-DOTATOC, SomaKit TOC (edotreotide) is a small molecule pharmaceutical. Edotreotide was first approved as Ga-68-DOTATOC on 2016-12-08. It has been approved in Europe to treat neuroendocrine tumors and radionuclide imaging. It is known to target somatostatin receptor type 2.

 

Trade Name

 

SomaKit TOC
 

Common Name

 

edotreotide
 

ChEMBL ID

 

CHEMBL408350
 

Indication

 

neuroendocrine tumors, radionuclide imaging
 

Drug Class

 

Peptides: inhibition of growth hormone release

Image (chem structure or protein)

Edotreotide structure rendering